The Inhibitory Effects of Rosmarinic Acid on RANKL-Mediated Osteoclastogenesis, F-actin Ring Formation and Bone Resorption through the Suppression of the NF-κB Signaling Pathway
DOI:
https://doi.org/10.48048/tis.2026.11189Keywords:
Rosmarinic acid, Osteoporosis, Osteoclast, Osteoclastogenesis, Osteoclast differentiation, Osteoclast-specific markers, F-actin ring formation, Bone resorption, Rosmarinic acid, Osteoporosis, Osteoclast, Osteoclastogenesis, Osteoclast differentiation, Osteoclast-specific markers, F-actin ring formation, Bone resorptionAbstract
The hyperactivation of osteoclasts is crucial in the process of bone degradation, leading to alterations in pathological bone resorption. The inhibition of excessive osteoclastogenesis and bone resorption through bioactive compounds derived from natural sources could represent an effective strategy for prevention or treatment. Rosmarinic acid (RA), a naturally occurring phenolic compound found in various aromatic plants, exhibits promising biological activities and therapeutic potential against multiple diseases. This study aimed to clarify the inhibitory effects and molecular mechanisms of RA on RANKL-induced osteoclastogenesis in RAW 264.7 cells. Treatment with RA at a non-toxic concentration resulted in a significant reduction in both the number of osteoclasts observed in TRAP staining and TRAP enzymatic activities. Quantitative real-time PCR analysis of mRNA gene expression revealed that RA significantly downregulated the expression of seven osteoclast-specific markers, including TRAF6, TRAP, NFATc1, c-Fos, Cathepsin K, MMP-9, and DC-STAMP. Furthermore, western blot analysis demonstrated that RA significantly suppressed the expression of osteoclast-specific proteins such as TRAF6, NFATc1, c-Fos, Cathepsin K, MMP-9, and DC-STAMP, as well as the phosphorylation of IκBα and NF-κB p65 signaling proteins. Additionally, RA was found to reduce F-actin ring formation and the area of bone resorption pits. In conclusion, RA effectively inhibits osteoclastogenesis, F-actin ring formation, and bone resorption by suppressing the NF-κB signaling pathway. These findings suggest that RA could serve as an active ingredient in dietary supplements for diseases related to osteoclast activity, such as osteoporosis.
HIGHLIGHTS
- Rosmarinic acid inhibits RANKL-induced osteoclastogenesis in RAW 264.7 cells.
- Rosmarinic acid suppresses the TRAF6/NF-kB signaling pathway in RANKL-mediated osteoclastogenesis.
- Rosmarinic acid down-regulates the gene and protein expression of osteoclast-specific markers during osteoclastogenesis.
- Rosmarinic acid decreases the F-actin ring formation and bone resorption.
GRAPHICAL ABSTRACT
Downloads
References
S Bolamperti, I Villa and A Rubinacci. Bone remodeling: An operational process ensuring survival and bone mechanical competence. Bone Research 2022; 10(1), 48.
V Daponte, K Henke and H Drissi. Current perspectives on the multiple roles of osteoclasts: Mechanisms of osteoclast–osteoblast communication and potential clinical implications. eLife 2024; 13, 95083.
MM Tang, YJ Chen, JY Wu, A Amin, XM Zhou, C Jin, GY Chen and ZL Yu. Ethyl acetate extract of the Musa nana flower inhibits osteoclastogenesis and suppresses NF-κB and MAPK pathways. Food and Function 2021; 12(22), 11586-11598.
H Xu, Y Jia, J Li, X Huang, L Jiang, T Xiang, Y Xie, X Yang, T Liu, Z Xiang and J Sheng. Niloticin inhibits osteoclastogenesis by blocking RANKL-RANK interaction and suppressing the AKT, MAPK, and NF-κB signaling pathways. Biomedicine and Pharmacotherapy 2022; 149, 112902.
D Xu, Y Lyu, X Chen, X Zhu, J Feng and Y Xu. Fructus Ligustri Lucidi ethanol extract inhibits osteoclastogenesis in RAW264.7 cells via the RANKL signaling pathway. Molecular Medicine Reports 2016; 14(5), 4767-4774.
B Langdahl, S Ferrari and DW Dempster. Bone modeling and remodeling: Potential as therapeutic targets for the treatment of osteoporosis. Therapeutic Advances in Musculoskeletal Disease 2016; 8(6), 225-235.
L Zhou, Q Liu, G Hong, F Song, J Zhao, J Yuan, J Xu, RX Tan, J Tickner, Q Gu and J Xu. Cumambrin A prevents OVX-induced osteoporosis Via the inhibition of osteoclastogenesis, bone resorption, and RANKL signaling pathways. The FASEB Journal 2019; 33(6), 6726-6735.
H Jin, Z Shao, Q Wang, J Miao, X Bai, Q Liu, H Qiu, C Wang, Z Zhang, T Jennifer, X Wang and J Xu. Sclareol prevents ovariectomy-induced bone loss in vivo and inhibits osteoclastogenesis in vitro via suppressing NF-κB and MAPK/ERK signaling pathways. Food and Function 2019; 10(10), 6556-6567.
H Chen, C Fang, X Zhi, S Song, Y Gu, X Chen, J Cui, Y Hu, W Weng, Q Zhou, Y Wang, Y Wang, H Jiang, X Li, L Cao, X Chen and JA-OX Su. Neobavaisoflavone inhibits osteoclastogenesis through blocking RANKL signalling-mediated TRAF6 and c-Src recruitment and NF-κB, MAPK and Akt pathways. Journal of Cellular and Molecular Medicine 2020; 24(16), 9067-9084.
JM Lee, MJ Kim, SJ Lee, BG Kim, JY Choi, SM Lee, HJ Ham, JM Koh, JH Jeon and IK Lee. PDK2 deficiency prevents ovariectomy-induced bone loss in mice by regulating the RANKL-NFATc1 pathway during osteoclastogenesis. Journal of Bone and Mineral Research 2021; 36(3), 553-566.
W Boonyarikpunchai, S Sukrong and P Towiwat. Antinociceptive and anti-inflammatory effects of rosmarinic acid isolated from Thunbergia laurifolia Lindl. Pharmacology Biochemistry and Behavior 2014; 124, 67-73.
AS Marchev, LV Vasileva, KM Amirova, MS Savova, IK Koycheva, ZP Balcheva-Sivenova, SM Vasileva and MI Georgiev. Rosmarinic acid - from bench to valuable applications in food industry. Trends in Food Science and Technology 2021; 117, 182-193.
K Pintha, P Tantipaiboonwong, S Yodkeeree, W Chaiwangyen, O Chumphukam, O Khantamat, C Khanaree, N Kangwan, B Thongchuai and M Suttajit. Thai perilla (Perilla frutescens) leaf extract inhibits human breast cancer invasion and migration. Maejo International Journal of Science and Technology 2018; 12(2), 112-123.
M Nadeem, M Imran, TA Gondal, A Imran, M Shahbaz, RM Amir, MW Sajid, TB Qaisrani, M Atif, G Hussain, B Salehi, EA Ostrander, M Martorell, J Sharifi-Rad, WC Cho and N Martins. Therapeutic potential of rosmarinic Acid: A Comprehensive Review. Applied Sciences 2019; 9(15), 3139.
H Harindranath, A Susil, S Rajeshwari, M Sekar and BRP Kumar. Unlocking the potential of Rosmarinic acid: A review on extraction, isolation, quantification, pharmacokinetics and pharmacology. Phytomedicine Plus 2025; 5(1), 100726.
O Wanachewin, K Boonmaleerat, P Pothacharoen, V Reutrakul, P Kongtawelert. Sesamin stimulates osteoblast differentiation through p38 and ERK1/2 MAPK signaling pathways. BMC Complementary and Alternative Medicine 2012; 12, 71.
KJ Livak and TD Schmittgen. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT) Method. Methods 2001; 25(4), 402-408.
O Wanachewin, P Pothacharoen, P Kongtawelert and T Phitak. Inhibitory effects of sesamin on human osteoclastogenesis. Archives of Pharmacal Research 2017; 40(10), 1186-1196.
P Collin-Osdoby and P Osdoby. RANKL-mediated osteoclast formation from murine RAW 264.7 cells. Methods in Molecular Biology 2011; 816, 187-202.
K Kim, TH Kim, HJ Ihn, JE Kim, JY Choi, HI Shin and EK Park. Inhibitory effect of purpurogallin on osteoclast differentiation in vitro through the downregulation of c-Fos and NFATc1. International Journal of Molecular Sciences 2018; 19(2), 601.
H Takayanagi. Osteoimmunology: Shared mechanisms and crosstalk between the immune and bone systems. Nature Reviews Immunology 2007; 7, 292-304.
K Matsuo, DL Galson, C Zhao, L Peng, C Laplace, KZQ Wang, MA Bachler, H Amano, H Aburatani, H Ishikawa and EF Wagner. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. Journal of Biological Chemistry 2004; 279(25), 26475-26480.
A Omori, Y Yoshimura, Y Deyama and K Suzuki. Rosmarinic acid and arbutin suppress osteoclast differentiation by inhibiting superoxide and NFATc1 downregulation in RAW 264.7 cells. Biomedical Reports 2015; 3(4), 483-490.
K Kim, SH Lee, JH Kim, Y Choi and N Kim. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Molecular Endocrinology 2008; 22(1), 176-185.
I Song, JH Kim, K Kim, HM Jin, BU Youn and N Kim. Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation. FEBS Letters 2009; 583(14), 2435-2440.
P Ballanti, S Minisola, MT Pacitti, L Scarnecchia, R Rosso, GF Mazzuoli and E Bonucci. Tartrate-resistant acid phosphate activity as osteoclastic marker: Sensitivity of cytochemical assessment and serum assay in comparison with standardized osteoclast histomorphometry. Osteoporosis International 1997; 7(1), 39-43.
R Dai, Z Wu, HY Chu, J Lu, A Lyu, J Liu and G Zhang. Cathepsin K: The action in and beyond bone. Frontiers in Cell and Developmental Biology 2020; 8, 433.
SR Wilson, C Peters, P Saftig and D Bromme. Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption. Journal of Biological Chemistry 2009; 284(4), 2584-2592.
K Sundaram, R Nishimura, J Senn, RF Youssef, SD London and SV Reddy. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Experimental Cell Research 2007; 313(1), 168-178.
M Yagi, T Miyamoto, Y Sawatani, K Iwamoto, N Hosogane, N Fujita, K Morita, K Ninomiya, T Suzuki, K Miyamoto, Y Oike, M Takeya, Y Toyama and T Suda. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. Journal of Experimental Medicine 2005; 202(3), 345-351.
ML Yen, PN Hsu, HJ Liao, BH Lee and HF Tsai. TRAF-6 dependent signaling pathway is essential for TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation. PLOS ONE 2012; 7(6), 38048.
G Zhu, Z Cheng, Y Huang, W Zheng, S Yang, C Lin and J Ye. TRAF6 promotes the progression and growth of colorectal cancer through nuclear shuttle regulation NF-B/c-jun signaling pathway. Life Sciences 2019; 235, 116831.
T Jiang, T Xia, F Qiao, N Wang, Y Jiang and H Xin. Role and Regulation of Transcription Factors in Osteoclastogenesis. International Journal of Molecular Sciences 2023; 24(22), 16175.
JH Kim and N Kim. Regulation of NFATc1 in Osteoclast Differentiation. Journal of Bone Metabolism 2014; 21(4), 233-241.
JCA Boeyens, V Deepak, WH Chua, MC Kruger, AM Joubert and M Coetzee. Effects of omega-3 and omega-6 polyunsaturated fatty acids on RANKL-induced osteoclast differentiation of RAW264.7 cells: A comparative in vitro study. Nutrients 2014, 6(7), 2584-2601.
V Iotsova, J Caamano, J Loy, Y Yang, A Lewin and R Bravo. Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nature Medicine 1997; 3(11), 1285-1289.
BF Boyce, Y Xiu, J Li, L Xing and Z Yao. NF-κB-mediated regulation of osteoclastogenesis. Endocrinology and Metabolism (Seoul) 2015; 30(1), 35-44.
J Zuo, LA Archer, A Cooper, KL Johnson, LS Holliday and C Dolce. Nuclear factor kappaB p65 phosphorylation in orthodontic tooth movement. Journal of Dental Research 2007; 86, 556-559.
Q Wang, Y Xie, QS Du, XJ Wu, X Feng, L Mei, JM McDonald and WC Xiong. Regulation of the formation of osteoclastic actin rings by proline-rich tyrosine kinase 2 interacting with gelsolin. Journal of Cell Biology 2003; 160(4), 565-575.
G Han, J Zuo and LS Holliday. Specialized roles for actin in osteoclasts: Unanswered questions and therapeutic opportunities. Biomolecules 2019; 9(1), 17.
Y Zhou, S Li, B Hong, Z Wang, Y Shao, M Wu and J Wang. Mechanisms of isorhamnetin inhibition of osteoclast differentiation: Insights from molecular dynamics simulations and in vitro/in vivo experiments. Frontiers in Pharmacology 2025; 16, 1551257.
W Cen, S Reinert, M Avci-Adali, D Alexander and F Umrath. A simple pit assay protocol to visualize and quantify osteoclastic resorption in vitro. Journal of Visualized Experiments 2022; 184, 64016.
DMH Merrild, DC Pirapaharan, CM Andreasen, P Kjærsgaard-Andersen, AMJ Moller, M Ding, JM Delaisse and K Soe. Pit- and trench-forming osteoclasts: A distinction that matters. Bone Research 2015; 3, 15032.
Published
Issue
Section
License
Copyright (c) 2025 Walailak University
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
